Global Vaccine Safety

Building capacity and enhancing vaccine pharmacovigilance in Pakistan

At the request of the MoH Pakistan, WHO organized an AEFI surveillance and monitoring workshop in Islamabad from 23rd to 26th August 2016. The 27 participants included professionals from the Drug Regulatory Authority of Pakistan, the National Program on Immunization and Pakistan Paediatric Association.

Inter-country workshop for the development of the « Adverse events following immunization surveillance manual »

From 25-28 July 2016, Benin, Burkina Faso, Burundi, Cameroon, Mali, Mauritania, Niger and Togo met in Ouagadougou, under the auspices of WHO to develop their « National adverse events following immunization (AEFI) surveillance manual ». National guidelines on vaccines pharmacovigilance will be validated by the authorities of each country by the end of the year. This workshop represents an important step forward to strenghten vaccines pharmacovigilance in the African region.

Fifth Global Vaccine Safety Initiative meeting, 26-27 October 2016, Addis Ababa, Ethiopia

GVSI 2015

The Global Vaccine Safety Initiative is the annual forum for Member States and key stakeholders in vaccine safety. Over two days, immunization program managers and pharmacovigilance staff of national regulatory authorities from more than 30 countries gather with representatives from UN agencies, academic institutions, pharmaceutical company umbrella organizations, partner and funding agencies to interact and exchange information on progress with implementation of national and global vaccine pharmacovigilance activities, share experiences, facilitate further partnerships and inter-sectorial collaborations, and define plans for further development.

For its fifth edition, the meeting will be organized in collaboration with the African Union Commission on 26-27 October 2016. The 5th GVSI will facilitate discussion pertaining to regulatory harmonization initiatives for pharmacovigilance of vaccines, vaccine safety communication and safety issues related to priority new vaccines.

Communicating about vaccine safety


WHO initiated a collaborative effort with communications experts, vaccine safety experts and partner agencies to develop a capacity-building approach integrating AEFI surveillance and vaccine safety communications. On 22-23 June 2016, a workshop was held to explore strategies for this approach and its dissemination at Regional/Country level.

The group agreed that the overarching goal of the project was to encourage AEFI reporting globally. Field-level understanding of AEFIs and risk communication is essential to address parental concerns about AEFIs and to ensure continued uptake of vaccines. It was also acknowledged that political commitment at the highest level was critical to achieve this goal.

The Global Advisory Committee on Vaccine Safety celebrates 15 years of contributions

The decline of vaccine-preventable infectious diseases has been accompanied with increased attention to possible vaccine reactions. In response, the WHO established in 1999 the Global Advisory Committee on Vaccine Safety (GACVS) to provide sound technical advice on vaccine safety. As an independent scientific group, GACVS has been assessing risks related to vaccines to help immunization policy-makers, in both, national and global levels, and guide them in the development of strategies and mechanisms especially for low- and middle-income countries. A comprehensive paper discussing GACVS’ accomplishments, the evolution and the challenges encountered throughout the 15 years of its life, has recently been published (Asturias EJ, et al., 2016 - )


Looking for reliable information on vaccine safety?

Contact us

Global Vaccine Safety
World Health Organization